About the Cancer Biotechnology Session
Cancer research is increasingly intertwined with biotechnology, leveraging cutting-edge tools and methodologies to unravel the complexities of this disease. From high-resolution imaging techniques facilitating early detection to customized therapies tailored to individual genetic profiles, biotechnology is reshaping how we approach cancer treatment. Biomarker identification, genomic sequencing, and precision medicine strategies are at the forefront, guiding clinicians towards more targeted and effective interventions. Moreover, innovative drug delivery systems, like nanoparticles and gene editing technologies, hold promise for reducing side effects and enhancing therapeutic outcomes. This fusion of cancer research and biotechnology heralds a new era in oncology, offering unprecedented opportunities to combat this formidable adversary and improve patient care worldwide.
Topics Covered in Cancer Biotechnology
Recombinant Antibodies
Gene Editing Tools
Nanoparticle Delivery
Cell Therapy Manufacturing
Biomarker Assay Development
Synthetic Biology
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Biotechnology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Biotechnology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Biotechnology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Biotechnology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Biotechnology Conference 2027 — FAQs
What is the Cancer Biotechnology track at CIOC 2027?
The Cancer Biotechnology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Biotechnology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Biotechnology sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Biotechnology are all welcome — whether presenting or attending.
Can I present my research in the Cancer Biotechnology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Biotechnology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Biotechnology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.